e-learning
resources
Munich 2014
Sunday, 07.09.2014
Sarcoidosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Biomarkers in sarcoidois follow-up: Angiotensin-converting enzyme or chitotriosidase?
M. Harlander, M. Zupancic, B. Salobir, M. Tercelj (Ljubljana, Slovenia)
Source:
International Congress 2014 – Sarcoidosis
Session:
Sarcoidosis
Session type:
Poster Discussion
Number:
462
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Harlander, M. Zupancic, B. Salobir, M. Tercelj (Ljubljana, Slovenia). Biomarkers in sarcoidois follow-up: Angiotensin-converting enzyme or chitotriosidase?. Eur Respir J 2014; 44: Suppl. 58, 462
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Assessing sarcoidosis activity: Is serum chitotriosidase a reliable marker? Study of 430 patients and 264 healthy controls
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014
Atypical variants of clinical course of sarcoidosis
Source: International Congress 2014 – ILDs 6
Year: 2014
Does the
BTNL2
genotype influence the course of disease in Danish sarcoidosis patients?
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014
Diagnosis of cardiac sarcoidosis: A crossectional study in 327 consecutive patients
Source: International Congress 2014 – Sarcoidosis
Year: 2014
Interleukin-6 in systemic sclerosis and potential correlation with pulmonary involvement
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Serum levels of sestrin 2 in patients with sarcoidosis
Source: International Congress 2014 – ILDs 6
Year: 2014
Cognitive failure in sarcoidosis
Source: International Congress 2014 – Sarcoidosis
Year: 2014
Serum angiotensin-converting enzyme activity in lymphangioleiomyomatosis
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Predictors of cardiovascular events in newly diagnosed patients with sarcoidosis
Source: International Congress 2014 – Sarcoidosis
Year: 2014
Lymphangioleiomyomatosis in TOSCA - TuberOus SClerosis registry to increAse disease awareness
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study
Source: International Congress 2014 – IPF and surroundings
Year: 2014
Pregnancy course in patients with interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014
European pulmonary alveolar proteinosis network (EuPAPNet): Results from biomarkers´ investigation
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014
Clinical features and prognosis of 108 patients with lymphangioleiomyomatosis
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014
How many patients require corticosteroid treatment in sarcoidosis? – Preliminary study
Source: International Congress 2014 – Sarcoidosis
Year: 2014
Neuroendocrine cell hyperplasia (NEHI) and NEHI Syndrome: Lung biopsy necessary?
Source: International Congress 2014 – ILDs 4
Year: 2014
Comorbidities associated with sarcoidosis – Results from long-term observational study
Source: International Congress 2014 – Sarcoidosis
Year: 2014
Predictive Findings of Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Aetiological panorama in the diagnosis of interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014
Reduction in disease progression with nintedanib in the INPULSIS™ trials
Source: International Congress 2014 – Clinical trials in IPF
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept